Búsqueda | Portal de Búsqueda de la BVS España

1.

Substance use in individuals at clinical high risk of psychosis.

Buchy, L; Cadenhead, K S; Cannon, T D; Cornblatt, B A; McGlashan, T H; Perkins, D O; Seidman, L J; Tsuang, M T; Walker, E F; Woods, S W; Heinssen, R; Bearden, C E; Mathalon, D; Addington, J.

Psychol Med; 45(11): 2275-84, 2015 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-25727300

2.

Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.

Auther, A M; Cadenhead, K S; Carrión, R E; Addington, J; Bearden, C E; Cannon, T D; McGlashan, T H; Perkins, D O; Seidman, L; Tsuang, M; Walker, E F; Woods, S W; Cornblatt, B A.

Acta Psychiatr Scand; 132(1): 60-8, 2015 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-25572323

3.

Attenuated psychosis syndrome: ready for DSM-5.1?

Fusar-Poli, P; Carpenter, W T; Woods, S W; McGlashan, T H.

Annu Rev Clin Psychol; 10: 155-92, 2014.

Artículo en Inglés | MEDLINE | ID: mdl-24471375

4.

Comparison of alternative models for personality disorders, II: 6-, 8- and 10-year follow-up.

Morey, L C; Hopwood, C J; Markowitz, J C; Gunderson, J G; Grilo, C M; McGlashan, T H; Shea, M T; Yen, S; Sanislow, C A; Ansell, E B; Skodol, A E.

Psychol Med; 42(8): 1705-13, 2012 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-22132840

5.

The association of personality disorders with the prospective 7-year course of anxiety disorders.

Ansell, E B; Pinto, A; Edelen, M O; Markowitz, J C; Sanislow, C A; Yen, S; Zanarini, M; Skodol, A E; Shea, M T; Morey, L C; Gunderson, J G; McGlashan, T H; Grilo, C M.

Psychol Med; 41(5): 1019-28, 2011 May.

Artículo en Inglés | MEDLINE | ID: mdl-20836909

6.

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.

Devoe, D J; Lu, L; Cannon, T D; Cadenhead, K S; Cornblatt, B A; McGlashan, T H; Perkins, D O; Seidman, L J; Tsuang, M T; Woods, S W; Walker, E F; Mathalon, D H; Bearden, C E; Addington, J.

Schizophr Res; 227: 28-37, 2021 01.

Artículo en Inglés | MEDLINE | ID: mdl-32362460

7.

Early identification of non-remission in first-episode psychosis in a two-year outcome study.

Simonsen, Erik; Friis, S; Opjordsmoen, S; Mortensen, E L; Haahr, U; Melle, I; Joa, I; Johannessen, J O; Larsen, T K; Røssberg, J I; Rund, B R; Vaglum, P; McGlashan, T H.

Acta Psychiatr Scand; 122(5): 375-83, 2010 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-20722632

8.

A 2-year follow-up of involuntary admission's influence upon adherence and outcome in first-episode psychosis.

Opjordsmoen, S; Friis, S; Melle, I; Haahr, U; Johannessen, J O; Larsen, T K; Røssberg, J I; Rund, B R; Simonsen, E; Vaglum, P; McGlashan, T H.

Acta Psychiatr Scand; 121(5): 371-6, 2010 May.

Artículo en Inglés | MEDLINE | ID: mdl-20085554

9.

Improvement in borderline personality disorder in relationship to age.

Tracie Shea, M; Edelen, M O; Pinto, A; Yen, S; Gunderson, J G; Skodol, A E; Markowitz, J; Sanislow, C A; Grilo, C M; Ansell, E; Daversa, M T; Zanarini, M C; McGlashan, T H; Morey, L C.

Acta Psychiatr Scand; 119(2): 143-8, 2009 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-18851719

10.

Personality traits as prospective predictors of suicide attempts.

Yen, S; Shea, M T; Sanislow, C A; Skodol, A E; Grilo, C M; Edelen, M O; Stout, R L; Morey, L C; Zanarini, M C; Markowitz, J C; McGlashan, T H; Daversa, M T; Gunderson, J G.

Acta Psychiatr Scand; 120(3): 222-9, 2009 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-19298413

11.

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.

Shakeel, M K; Lu, L; Cannon, T D; Cadenhead, K S; Cornblatt, B A; McGlashan, T H; Perkins, D O; Seidman, L J; Tsuang, M T; Woods, S W; Walker, E F; Mathalon, D H; Bearden, C E; Addington, J.

Schizophr Res; 204: 334-336, 2019 02.

Artículo en Inglés | MEDLINE | ID: mdl-30181061

12.

Premorbid adjustment, onset types, and prognostic scaling: still informative?

McGlashan, T H.

Schizophr Bull; 34(5): 801-5, 2008 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-18586693

13.

Is active psychosis neurotoxic?

McGlashan, T H.

Schizophr Bull; 32(4): 609-13, 2006 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-16914639

14.

Insights into psychosis risk from leukocyte microRNA expression.

Jeffries, C D; Perkins, D O; Chandler, S D; Stark, T; Yeo, E; Addington, J; Bearden, C E; Cadenhead, K S; Cannon, T D; Cornblatt, B A; Mathalon, D H; McGlashan, T H; Seidman, L J; Walker, E F; Woods, S W; Glatt, S J; Tsuang, M.

Transl Psychiatry; 6(12): e981, 2016 12 13.

Artículo en Inglés | MEDLINE | ID: mdl-27959328

15.

Testing DSM-III symptom criteria for schizotypal and borderline personality disorders.

McGlashan, T H.

Arch Gen Psychiatry; 44(2): 143-8, 1987 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-3813809

16.

The Chestnut Lodge follow-up study. III. Long-term outcome of borderline personalities.

McGlashan, T H.

Arch Gen Psychiatry; 43(1): 20-30, 1986 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-3942471

17.

Schizotypal personality disorder. Chestnut Lodge follow-up study: VI. Long-term follow-up perspectives.

McGlashan, T H.

Arch Gen Psychiatry; 43(4): 329-34, 1986 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-3954556

18.

The prediction of outcome in chronic schizophrenia. IV. The Chestnut Lodge follow-up study.

McGlashan, T H.

Arch Gen Psychiatry; 43(2): 167-76, 1986 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-3947211

19.

The borderline syndrome. I. Testing three diagnostic systems.

McGlashan, T H.

Arch Gen Psychiatry; 40(12): 1311-8, 1983 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-6651466

20.

The borderline syndrome. II. Is it a variant of schizophrenia or affective disorder?

McGlashan, T H.

Arch Gen Psychiatry; 40(12): 1319-23, 1983 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-6651467

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Substance use in individuals at clinical high risk of psychosis.

Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.

Attenuated psychosis syndrome: ready for DSM-5.1?

Comparison of alternative models for personality disorders, II: 6-, 8- and 10-year follow-up.

The association of personality disorders with the prospective 7-year course of anxiety disorders.

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.

Early identification of non-remission in first-episode psychosis in a two-year outcome study.

A 2-year follow-up of involuntary admission's influence upon adherence and outcome in first-episode psychosis.

Improvement in borderline personality disorder in relationship to age.

Personality traits as prospective predictors of suicide attempts.

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.

Premorbid adjustment, onset types, and prognostic scaling: still informative?

Is active psychosis neurotoxic?

Insights into psychosis risk from leukocyte microRNA expression.

Testing DSM-III symptom criteria for schizotypal and borderline personality disorders.

The Chestnut Lodge follow-up study. III. Long-term outcome of borderline personalities.

Schizotypal personality disorder. Chestnut Lodge follow-up study: VI. Long-term follow-up perspectives.

The prediction of outcome in chronic schizophrenia. IV. The Chestnut Lodge follow-up study.

The borderline syndrome. I. Testing three diagnostic systems.

The borderline syndrome. II. Is it a variant of schizophrenia or affective disorder?